BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hoffmann P, Wehling C, Krisam J, Pfeiffenberger J, Belling N, Gauss A. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis. World J Gastroenterol 2019; 25(13): 1603-1617 [PMID: 30983820 DOI: 10.3748/wjg.v25.i13.1603]
URL: https://www.wjgnet.com/1007-9327/full/v25/i13/1603.htm
Number Citing Articles
1
Roberto Manzini, Marlene Schwarzfischer, Kirstin Atrott, Andrea Laimbacher, Silvia Lang, Marcin Wawrzyniak, Andreas Rickenbacher, Matthias Turina, Petr Hruz, Donata Lissner, Britta Siegmund, Gerhard Rogler, Michael Scharl, Marianne R Spalinger. Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental ColitisInflammatory Bowel Diseases 2021; 27(12): 1986 doi: 10.1093/ibd/izab063
2
Juan Luo, Yijie Wang, Xiangqian Dong, Wen Wang, Yanju Mu, Yang Sun, Fengrui Zhang, Yinglei Miao. miR-642a-5p increases glucocorticoid sensitivity by suppressing the TLR4 signalling pathway in THP-1 cellsBiochemistry and Biophysics Reports 2022; 32: 101356 doi: 10.1016/j.bbrep.2022.101356
3
Sujaata Dwadasi, Maryam Zafer, Donald Goens, Raghavendra Paknikar, Sushila Dalal, Russell D Cohen, Joel Pekow, David T Rubin, Atsushi Sakuraba, Dejan Micic. Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative ColitisInflammatory Bowel Diseases 2021; 27(10): 1620 doi: 10.1093/ibd/izaa326
4
Jacob E. Ollech, Sujaata Dwadasi, Victoria Rai, Noam Peleg, Inessa Normatov, Amanda Israel, Philip H. Sossenheimer, Britt Christensen, Joel Pekow, Sushila R. Dalal, Atsushi Sakuraba, Russell D. Cohen, David T. Rubin. Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitisAlimentary Pharmacology & Therapeutics 2020; 51(6): 637 doi: 10.1111/apt.15616
5
Shankar Kumar, Richard Pollok, David Goldsmith. Renal and Urological Disorders Associated With Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2022;  doi: 10.1093/ibd/izac140
6
Morris Gordon, Vassiliki Sinopoulou, Anthony K Akobeng, Mirela Pana, Rehab Gasiea, Gordon William Moran. Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitisCochrane Database of Systematic Reviews 2022; 2022(4) doi: 10.1002/14651858.CD007216.pub2
7
G. Pellino, D. S. Keller, G. M. Sampietro, M. Carvello, V. Celentano, C. Coco, F. Colombo, A. Geccherle, G. Luglio, M. Rottoli, M. Scarpa, G. Sciaudone, G. Sica, L. Sofo, R. Zinicola, S. Leone, S. Danese, A. Spinelli, G. Delaini, F. Selvaggi, Imerio Angriman, Paola Caprino, Francesca Di Candido, Mirko Di Ruscio, Silvio Laureti, Gilberto Poggioli, Gianluca Rizzo, Giulia Roda, Franco Sacchetti, Stefano Scaringi, Bruno Sensi, Angela Variola, Committee Gianluca Pellino, Deborah S. Keller, Gianluca M. Sampietro, Salvatore Leone, Silvio Danese, Antonino Spinelli, GianGaetano Delaini, Francesco Selvaggi. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitisTechniques in Coloproctology 2020; 24(5): 397 doi: 10.1007/s10151-020-02175-z
8
Ananya S Agnihotri, C.G. Ann Maria, Anitha Varghese, Pratap Mane, Brahmananda Chakraborty, Nidhin M. CoFe2O4-APTES nanocomposite for the selective determination of tacrolimus in dosage forms: Perspectives from computational studiesSurfaces and Interfaces 2022; 35: 102406 doi: 10.1016/j.surfin.2022.102406
9
Satoshi Nakata, Kazuki Kakimoto, Keijiro Numa, Naohiko Kinoshita, Yuka Kawasaki, Yoshihiro Tatsumi, Hideki Tawa, Ryoji Koshiba, Yuki Hirata, Kazuhiro Ota, Naokuni Sakiyama, Yuichi Kojima, Hiroki Nishikawa, Takuya Inoue, Toshihisa Takeuchi, Shinya Fukunishi, Takako Miyazaki, Shiro Nakamura, Kazuhide Higuchi. Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative ColitisDigestion 2022; 103(5): 339 doi: 10.1159/000524594
10
Iria Seoane-Viaño, Noemí Gómez-Lado, Héctor Lázare-Iglesias, Xurxo García-Otero, José Ramón Antúnez-López, Álvaro Ruibal, Juan Jesús Varela-Correa, Pablo Aguiar, Abdul W. Basit, Francisco J. Otero-Espinar, Miguel González-Barcia, Alvaro Goyanes, Asteria Luzardo-Álvarez, Anxo Fernández-Ferreiro. 3D Printed Tacrolimus Rectal Formulations Ameliorate Colitis in an Experimental Animal Model of Inflammatory Bowel DiseaseBiomedicines 2020; 8(12): 563 doi: 10.3390/biomedicines8120563
11
Fang Zhu, Jujia Zheng, Fang Xu, Yiyuan Xi, Jun Chen, Xiangwei Xu. Resveratrol Alleviates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice by Mediating PI3K/Akt/VEGFA PathwayFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.693982
12
Qinghui Jia, Haihua Zhang, Yongmei Su, Xin Liu, Jiangsong Bai, Wuying Lang, Qiumei Shi, Minshan Feng. Strictosamide alleviates the inflammation in an acute ulcerative colitis (UC) modelJournal of Physiology and Biochemistry 2021; 77(2): 283 doi: 10.1007/s13105-021-00796-y
13
Chenthan Krishnakumar, Ashwin N. Ananthakrishnan, Brendan M. Boyle, Anne M. Griffiths, Neal S. LeLeiko, David R. Mack, James F. Markowitz, Joel R. Rosh, Cary G. Sauer, Thomas D. Walters, Erin Bonkowski, Lee A. Denson, Jeffrey S. Hyams, Subra Kugathasan. Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative ColitisJournal of Pediatric Gastroenterology & Nutrition 2022; 74(1): 72 doi: 10.1097/MPG.0000000000003291
14
Zhenhua Bian, Yuwen Qin, Lin Li, Lianlin Su, Chenghao Fei, Yu Li, Minmin Hu, Xiaowei Chen, Wei Zhang, Chunqin Mao, Xiaohang Yuan, Tulin Lu, De Ji. Schisandra chinensis (Turcz.) Baill. Protects against DSS-induced colitis in mice: Involvement of TLR4/NF-κB/NLRP3 inflammasome pathway and gut microbiotaJournal of Ethnopharmacology 2022; 298: 115570 doi: 10.1016/j.jep.2022.115570
15
Ciclosporin/mercaptopurine/tacrolimusReactions Weekly 2019; 1761(1): 109 doi: 10.1007/s40278-019-64481-1